Development of a liquid chromatography-based versatile bioanalysis for bevacizumab based on pretreatment combining aptamer affinity purification and centrifugal ultrafiltration concentration
Analytical Sciences · 2023
DOI: 10.1007/s44211-023-00417-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Sciences, 2023. Verfasst von Kenichiro Todoroki und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Analytical and Bioanalytical Chemistry, School of Pharmaceutical Sciences, University of Shizuoka, 52-1, Yada, Suruga-Ku, Shizuoka, 422…. Hauptthemen laut MEDLINE: Bevacizumab, Aptamers, Nucleotide. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Daiichi-Sankyo.
Abstract (Originalsprache)
We report on the development of a versatile and accurate bioanalytical method for bevacizumab using a pretreatment method combining affinity purification with anti-idiotypic DNA aptamers and centrifugal ultrafiltration concentration, followed by liquid chromatography (LC)-fluorescence analysis. An affinity purification method using Sepharose beads as an affinity support removed immunoglobulin G and a large amount of coexisting substances in the serum sample. Purified bevacizumab was separated as a single peak by conventional LC and detected fluorometrically, showing good linearity (R2 = 0.999) in the range of 5-200 μg/mL, sufficient to analyze bevacizumab concentrations in the blood of bevacizumab-treated patients. By combining this purification method with a concentration method using a centrifugal filtration device that inhibits non-specific adsorption of bevacizumab, the quantitative range was reduced by a factor of 10 while showing good linearity (R2 = 0.999) in the 0.5-20 μg/mL range. The developed analytical method is expected to be used not only for general bioanalysis of therapeutic mAbs in clinical settings, but also for next-generation antibody drugs that show drug efficacy at low concentrations and for analysis of trace samples.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Analytical and Bioanalytical Chemistry, School of Pharmaceutical Sciences, University of Shizuoka, 52-1, Yada, Suruga-Ku, Shizuoka, 422-8526, Japan. todoroki@u-shizuoka-ken.ac.jp.
- Department of Analytical and Bioanalytical Chemistry, School of Pharmaceutical Sciences, University of Shizuoka, 52-1, Yada, Suruga-Ku, Shizuoka, 422-8526, Japan.
- Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, 2-24-16 Naka-Cho, Koganei, Japan.
- Laboratory of Analytical Chemistry, Faculty of Pharmacy, Meijo University, 150 Yagotoyama, Tempaku, Nagoya, 468-8503, Japan.
- Laboratory of Community Pharmaceutical Practice and Science, Gifu Pharmaceutical University, Daigaku-Nishi 1-25-4, Gifu, 501-1196, Japan.
Förderung
- Japan Society for the Promotion of Science
- Daiichi-Sankyo
Zitieren
APA
Todoroki, K., Hamada, D., Yamada, T., Saito, T., Shimizu, Y., Sugiyama, E., Mizuno, H., Hayashi, H., Tsukakoshi, K., & Ikebukuro, K. (2023). Development of a liquid chromatography-based versatile bioanalysis for bevacizumab based on pretreatment combining aptamer affinity purification and centrifugal ultrafiltration concentration. Analytical Sciences. https://doi.org/10.1007/s44211-023-00417-2
Vancouver
Todoroki K, Hamada D, Yamada T, Saito T, Shimizu Y, Sugiyama E, et al. Development of a liquid chromatography-based versatile bioanalysis for bevacizumab based on pretreatment combining aptamer affinity purification and centrifugal ultrafiltration concentration. Analytical Sciences. 2023. doi:10.1007/s44211-023-00417-2
BibTeX
@article{Todoroki2023,
author = {Todoroki, Kenichiro and Hamada, Daichi and Yamada, Tomohiro and Saito, Taro and Shimizu, Yutaka and Sugiyama, Eiji and Mizuno, Hajime and Hayashi, Hideki and Tsukakoshi, Kaori and Ikebukuro, Kazunori},
title = {Development of a liquid chromatography-based versatile bioanalysis for bevacizumab based on pretreatment combining aptamer affinity purification and centrifugal ultrafiltration concentration},
journal = {Analytical Sciences},
year = {2023},
doi = {10.1007/s44211-023-00417-2}
}
EUVIMED